Cena / účtovná hodnotae spoločnosti IMV

Aká je hodnota metriky Cena / účtovná hodnotae spoločnosti IMV?

Hodnota metriky Cena / účtovná hodnotae spoločnosti IMV, Inc. je -2.81

Aká je definícia metriky Cena / účtovná hodnotae?



Cena / učtovná hodnota (Price to book ratio) ukazateľ vyjadruje pomer medzi hodnotou spoločnosti a book value spoločnosti, čo je hodnota čistých aktív.

The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).

The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).

P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.

Cena / účtovná hodnotae spoločností v sektore Health Care sektor na TSX v porovnaní so spoločnosťou IMV

Čomu sa venuje spoločnosť IMV?

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

Firmy s metrikou cena / účtovná hodnotae podobnou spoločnosti IMV



  • Hodnota metriky Cena / účtovná hodnotae spoločnosti iHeartMedia je -2.82
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Futuris Co je -2.82
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Guyana Goldstrike je -2.82
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Sakthi Sugars je -2.82
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti ThermoGenesis Inc je -2.82
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti AEON Stores (Hong Kong) Co je -2.81
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti IMV je -2.81
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Spentex Industries je -2.81
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Bausch Health Companies Inc je -2.76
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Environmental Waste International je -2.75
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Emerald Inc je -2.74
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti DXI je -2.73
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti IMV je -2.70